Merck & Co. Inc. (MRK)

59.09
NYSE : Health Technology
Prev Close 59.13
Day Low/High 58.84 / 59.46
52 Wk Low/High 52.83 / 66.41
Avg Volume 11.22M
Exchange NYSE
Shares Outstanding 2.69B
Market Cap 159.08B
EPS 0.90
P/E Ratio 67.97
Div & Yield 1.92 (3.21%)
Teva Options Jump to Record Amid New CEO's Latest Bid for Turnaround

Teva Options Jump to Record Amid New CEO's Latest Bid for Turnaround

Teva options now total more than Pfizer and Merck combined.

Novice Trade: Pfizer

Novice Trade: Pfizer

The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.

Stocks Trade Higher Following Explosion at New York's Port Authority

Stocks Trade Higher Following Explosion at New York's Port Authority

Stocks turn higher on Monday.

FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review To Merck's KEYTRUDA® (pembrolizumab) For Treatment Of Relapsed Or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review To Merck's KEYTRUDA® (pembrolizumab) For Treatment Of Relapsed Or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced findings from the phase 2 KEYNOTE-170 trial investigating the use of KEYTRUDA ® (pembrolizumab), the company's anti-PD-1 therapy, in...

A Drug Giant, a Maker of Artificial Joints and Other Stocks That Look Good Short

MRK, PEGA, FNGN, RGNX and ZBH all recently were downgraded by TheStreet's Quant Ratings.

Merck Commemorates 30 Years Of MECTIZAN® Donation Program Progress

Merck Commemorates 30 Years Of MECTIZAN® Donation Program Progress

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced an expansion of the MECTIZAN ® Donation Program (MDP) to reach up to an additional 100 million people per year through 2025 as part...

Hot Trade: Merck

Hot Trade: Merck

I prefer a bullish put spread expiring in June.

New And Updated Data For Merck's KEYTRUDA® (pembrolizumab) And Updated Data On LYNPARZA® (olaparib) In Multiple Breast Cancer Subtypes To Be Presented At The 2017 San Antonio Breast Cancer Symposium (SABCS)

New And Updated Data For Merck's KEYTRUDA® (pembrolizumab) And Updated Data On LYNPARZA® (olaparib) In Multiple Breast Cancer Subtypes To Be Presented At The 2017 San Antonio Breast Cancer Symposium (SABCS)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new and updated data from six abstracts investigating KEYTRUDA ® (pembrolizumab), the company's anti-PD-1 therapy, as both...

Merck Becomes #28 Most Shorted Dow Stock, Replacing Apple

Merck Becomes #28 Most Shorted Dow Stock, Replacing Apple

The most recent short interest data has been released for the 11/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Wall Street at Records as GOP Tax Bill Heads to Senate Vote

Wall Street at Records as GOP Tax Bill Heads to Senate Vote

Wall Street ended at records as the Senate GOP's tax bill cleared the Senate Budget Committee, moving it toward the floor for a vote later this week.

Merck Announces Increased Quarterly Dividend And $10 Billion Share Repurchase Authorization

Merck Announces Increased Quarterly Dividend And $10 Billion Share Repurchase Authorization

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CFG, CRAY, JW.B, MRCC, NCI, PANL, PYDS, SABR, UBS, VEC Downgrades: CECE, KB, MRK, PFGC Initiations: ZTO Read on to get TheStreet Quant Ratings' detailed report:

Wall Street Finishes in the Green After Two Weeks of Losses

Wall Street Finishes in the Green After Two Weeks of Losses

Gains in consumer discretionary and industrial names pushed Wall Street higher on Monday. Tax reform concerns continue to perplex investors.

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses

Gains in consumer discretionary names are leading Wall Street higher on Monday.

IBM Shares Fall After Warren Buffett Slashes His Stake by a Third

IBM Shares Fall After Warren Buffett Slashes His Stake by a Third

The billionaire investor cut his stake in Big Blue by a third during the most recent quarter, and has realized a loss of roughly half-a-billion dollars on his investment this year.

Merck Announces Final Results Of Any And All Tender Offers

Merck Announces Final Results Of Any And All Tender Offers

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today the final results of the previously announced offers to purchase (collectively, the "Offers") any and all of the outstanding notes listed...

Merck Announces Pricing Of Any And All Tender Offers

Merck Announces Pricing Of Any And All Tender Offers

Merck & Co., Inc.

Merck Receives Positive CHMP Opinion For PREVYMIS™ (letermovir) In The European Union

Merck Receives Positive CHMP Opinion For PREVYMIS™ (letermovir) In The European Union

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

Acadia, Dynavax Make the Biotech Mailbag

Acadia, Dynavax Make the Biotech Mailbag

Readers have asked about Acadia Pharmaceuticals and Dynavax Technologies, so we answer.

Care & Control Of Pet Diabetes Featuring Sugar & Spike (Photo: Business Wire)

Care & Control Of Pet Diabetes Featuring Sugar & Spike (Photo: Business Wire)

November is Pet Diabetes Month, and to raise awareness of diabetes in pets, Merck Animal Health (known as MSD Animal Health outside the United States and Canada) has launched Care & Control of Pet Diabetes Featuring...

Merck Announces Any And All Tender Offers

Merck Announces Any And All Tender Offers

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today the commencement of offers to purchase (collectively, the "Offers") any and all of the outstanding notes listed in the table below...

TheStreet Quant Rating: C+ (Hold)